Indofarma Tbk.
listed issuer 743 attachments mirroredOverview
Belum ada overview. AI akan membaca laporan tahunan dan prospektus INAF, lalu merangkum bisnis, produk, industri, pesaing, grup, serta website dan media sosial resminya.
Ringkasan AI dari dokumen emiten dan web; periksa sumbernya.
Intinya, beli INAF?
Belum ada analisis. AI akan mencari tahu kenapa harga INAF bergerak belakangan ini, lalu menilai layak dibeli atau tidak dari pengumuman, laporan keuangan, kepemilikan dan berita.
Bukan rekomendasi investasi — analisis AI dari keterbukaan informasi, harga dan berita. Periksa sumbernya sebelum mengambil keputusan.
Chart IDX · harian (EOD)
Musiman kinerja per tahun vs rata-rata
Pengumuman terbaru 25
Financial position Kuartal II / Second Quarter · Tidak Diaudit / Unaudit
| Figure (IDR) | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 | 30 Sep 2025 |
|---|---|---|---|---|
| Report posisi keuangan | ||||
| Total assets | 510.83B510,834,387,812 | 489.67B489,667,151,488 | 535.99B535,988,243,201 | 581.56B581,558,305,248 |
| Current assets | 100.10B100,095,117,093 | 75.92B75,923,743,978 | 119.23B119,231,963,692 | 164.45B164,454,180,826 |
| Non-aktif assets | 410.74B410,739,270,719 | 413.74B413,743,407,510 | 416.76B416,756,279,509 | 417.10B417,104,124,422 |
| Total liabilities | 1.25T1,250,907,081,957 | 1.20T1,204,190,229,575 | 1.24T1,242,930,855,603 | 1.47T1,472,496,150,741 |
| Equity | -740.07B-740,072,694,145 | -714.52B-714,523,078,087 | -706.94B-706,942,612,402 | -890.94B-890,937,845,493 |
| Paid-in capital | 309.93B309,926,750,000 | 309.93B309,926,750,000 | 309.93B309,926,750,000 | 309.93B309,926,750,000 |
| Retained earnings | -1.47T-1,466,737,283,514 | -1.44T-1,441,187,667,456 | -1.43T-1,433,607,201,771 | -1.48T-1,478,894,677,898 |
| Laba rugi komprehensif | ||||
| Revenue | 79.04B79,043,913,365 | 53.33B53,325,349,350 | — | 133.74B133,735,235,165 |
| Operating profit | -33.13B-33,130,081,743 | -7.58B-7,580,465,685 | — | -127.09B-127,091,065,180 |
| Net profit | -33.13B-33,130,081,743 | -7.58B-7,580,465,685 | — | -127.09B-127,091,065,180 |
| Comprehensive income | -33.13B-33,130,081,743 | -7.58B-7,580,465,685 | — | -127.09B-127,091,065,180 |
| EPS basic / diluted | -10.6900 / — | -2.4459 / — | — / — | -41.0100 / — |
| Rasio keuangan · derived | ||||
| Current ratio | 15.22% | 12.05% | 18.85% | 13.08% |
| ROA | -6.49% | -1.55% | — | -21.85% |
| ROE | 4.48% | 1.06% | — | 14.26% |
From the XBRL instance filed with IDX. Ratios are derived from the figures above, so they may differ in the last decimal from the issuers's own rounding.
What the company owns Property, plant and equipment, net of depreciation
| Asset class | Share | Net | Bruto | Depreciation |
|---|---|---|---|---|
| LAND Land | 180.64B180,640,947,727 | 180.64B180,640,947,727 | — | |
| BUILDING Building Leasehold Improvement | 75.48B75,479,248,528 | 196.88B196,879,370,671 | 121.40B121,400,122,143 | |
| MACHINERY Machinery Equipment | 36.51B36,505,137,844 | 151.64B151,638,025,381 | 115.13B115,132,887,537 | |
| OTHER Others | 24.50B24,495,674,286 | 82.53B82,530,814,670 | 58.04B58,035,140,384 | |
| MACHINERY Technical Equipment | 11.63B11,630,975,069 | 56.15B56,152,477,067 | 44.52B44,521,501,998 | |
| FURNITURE Furniture Office Equipment | 1.44B1,439,899,425 | 16.24B16,238,790,981 | 14.80B14,798,891,556 | |
| MACHINERY Technical Equipment Assets Under Construction | 292.15M292,148,649 | 292.15M292,148,649 | — | |
| VEHICLE Motor Vehicle | 93.04M93,036,887 | 930.37M930,368,858 | 837.33M837,331,971 |
Classes an issuers does not report are absent rather than zero — a company that leases all its land simply omits it.
Total assets over time
Asset transactions 3 Material, affiliated and conflict-of-interest deals
| Date | Type | Asset | Object | Value | % equity | Counterparties |
|---|---|---|---|---|---|---|
| 15 Sep 2025 | Transaksi Material | Other | Dalam rangka memenuhi ketentuan Peraturan clipped by the IDX form — full text in the attachment | 220.17B220,174,165,916 currency not stated | — | PT Biofarma (Persero) |
| 21 Mar 2024 | Transaksi Material | Other | Dalam rangka memenuhi ketentuan Peraturan clipped by the IDX form — full text in the attachment | 724.90B724,896,335,137 currency not stated | — | PT Bio Farma (Persero) |
| 21 Mar 2024 | Transaksi Afiliasi | Guarantee | Penjaminan Aset | 724.90B724,896,335,137 currency not stated | — | PT Bio Farma (Persero) |
Values marked “currency not stated” come from the IDX cover form, which gives a bare number. Several issuers state USD there, so these are not assumed to be rupiah.
Shareholder register from filings as last reported to IDX · the register below is the authoritative source
| Holder | Shares | Stake | Reporteran | Per | Open filing |
|---|---|---|---|---|---|
|
gunawan
control
|
100 | 100.00% | 1 | 20 Jul 2026 | Open filing |
| Sahat SIhombing | 0 | 0.00% | 31 Aug 2026 |
| Bio Farma (Persero) | 2,499,999,999 | 80.66% | 31 Aug 2026 |
| Didi Agus Mintadi | 0 | 0.00% | 31 Aug 2026 |
| Andi Prazos | 0 | 0.00% | 31 Aug 2026 |
| PT Asabri (Persero) - | 425,907,600 | 13.74% | 31 Aug 2026 |
| Negara Republik | 1 | 0.00% | 31 Mar 2026 |
| PT ASABRI (PERSERO) - DAPEN TN… | 227,533,850 | 7.34% | 31 Mar 2026 |
| BIO FARMA (PERSERO), PT | 2,499,999,999 | 80.66% | 31 Mar 2026 |
| Yeliandriani | 0 | 0.00% | 31 Aug 2025 |
| Laksono Trisnantoro | 0 | 0.00% | 31 Aug 2025 |
| Teddy Wibisana | 0 | 0.00% | 31 Aug 2025 |
| PUBLIK | 371,733,650 | 11.99% | 31 Jan 2024 |
| Jejen Nugraha | 0 | 0.00% | 31 Dec 2023 |
| Ariesta Krisnawan | 0 | 0.00% | 31 Dec 2023 |
| Agus Heru Darjono | 0 | 0.00% | 31 Dec 2023 |
| Achmad Ghufron Sirodj | 0 | 0.00% | 31 Dec 2023 |
| Kamelia Faisal | 0 | 0.00% | 31 Dec 2023 |
RUPS
Board
| Teddy Wibisana | Komite Audit | since Aug 2024 |
| Ferry Apriandi | Komite Audit | since Aug 2024 |
Change terbaru
Backup status
- Attachments
- 743
- Mirrored
- 741
- Pending
- 0
Ownership filings on this issuer
20 Jul 2026 INAF gunawan 100 → 100 0 100.00%
| Type | Shares | Price | Class | Date | Purpose |
|---|---|---|---|---|---|
| Penjualan | 100 | 1000000000000.00 | Saham dengan hak suara multiple | 20 Jul 2026 | Penjualan |